Finland M, Garner C, Wilcox C, Sabath L D
J Infect Dis. 1976 Nov;134 SUPPL:S297-307. doi: 10.1093/infdis/135.supplement_2.s297.
In vitro tests for susceptibility to amikacin and to four other aminoglycoside antibiotics were carried out with strains of many bacterial species by use of an agar dilution method and an inocula replicator. In general, amikacin was as active as or more active against most of the organims than kanamycin, neomycin, and streptomycin; in particular, amikacin was active against strains resistant to one or more of these three antibiotics. Amikacin was more active than gentamicin against strains of Nocardia asteroides and Providencia stuartii and also against gentamicin-resistant strains of some other gram-negative bacilli, notably Serratia marcescens. However, gentamicin was more active than amikacin against most of the other gram-positive and gram-negative bacteria that were tested. In comparative tests of four media, minimal inhibitory concentrations MICs) were greater in tests with Mueller-Hinton agar, and generally somewhat lower in those with heart infusion agar, than in tests with trypticase soy agar and nutrient agar. Inocula of a 1:1,000 dilution of culture generally gave MICs lower than those obtained with undiluted cultures; the differences were small with enterococci, but they were greater with amikacin than with gentamicin in tests on strains of Klebsiella pneumoniae. These findings generally confirm those previously reported by others.
采用琼脂稀释法和接种复制器,对多种细菌菌株进行了阿米卡星及其他四种氨基糖苷类抗生素的体外药敏试验。总体而言,阿米卡星对大多数微生物的活性与卡那霉素、新霉素和链霉素相当或更强;特别是,阿米卡星对耐这三种抗生素中一种或多种的菌株具有活性。阿米卡星对星形诺卡菌和斯氏普罗威登斯菌菌株以及对其他一些革兰氏阴性杆菌(尤其是粘质沙雷菌)的庆大霉素耐药菌株的活性比庆大霉素更强。然而,在对大多数其他测试的革兰氏阳性和革兰氏阴性细菌的试验中,庆大霉素比阿米卡星更具活性。在四种培养基的比较试验中,与胰蛋白酶大豆琼脂和营养琼脂试验相比,用穆勒-欣顿琼脂试验的最低抑菌浓度(MICs)更高,而用心浸液琼脂试验的MICs通常略低。1:1000稀释培养物的接种物产生的MICs通常低于未稀释培养物获得的MICs;肠球菌的差异较小,但在肺炎克雷伯菌菌株试验中,阿米卡星的差异比庆大霉素更大。这些发现总体上证实了其他人先前报道的结果。